212 related articles for article (PubMed ID: 12830005)
1. Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases.
Streetz KL; Tacke F; Leifeld L; Wüstefeld T; Graw A; Klein C; Kamino K; Spengler U; Kreipe H; Kubicka S; Müller W; Manns MP; Trautwein C
Hepatology; 2003 Jul; 38(1):218-29. PubMed ID: 12830005
[TBL] [Abstract][Full Text] [Related]
2. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
Klein C; Wüstefeld T; Assmus U; Roskams T; Rose-John S; Müller M; Manns MP; Ernst M; Trautwein C
J Clin Invest; 2005 Apr; 115(4):860-9. PubMed ID: 15761498
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS
Gastroenterology; 2005 Sep; 129(3):1005-18. PubMed ID: 16143138
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of gp130 and STAT3 activation in the rat hippocampus following transient forebrain ischemia.
Choi JS; Kim SY; Cha JH; Choi YS; Sung KW; Oh ST; Kim ON; Chung JW; Chun MH; Lee SB; Lee MY
Glia; 2003 Feb; 41(3):237-46. PubMed ID: 12528179
[TBL] [Abstract][Full Text] [Related]
5. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
6. Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice.
Wüstefeld T; Rakemann T; Kubicka S; Manns MP; Trautwein C
Hepatology; 2000 Sep; 32(3):514-22. PubMed ID: 10960443
[TBL] [Abstract][Full Text] [Related]
7. Lack of gp130 expression results in more bacterial infection and higher mortality during chronic cholestasis in mice.
Wuestefeld T; Klein C; Streetz KL; Beraza N; Schölmerich J; Burgart LJ; Zender L; Kubicka S; Baskin-Bey E; Gores GJ; Manns MP; Trautwein C
Hepatology; 2005 Nov; 42(5):1082-90. PubMed ID: 16250046
[TBL] [Abstract][Full Text] [Related]
8. No inhibition of IL-27 signaling by soluble gp130.
Scheller J; Schuster B; Hölscher C; Yoshimoto T; Rose-John S
Biochem Biophys Res Commun; 2005 Jan; 326(4):724-8. PubMed ID: 15607729
[TBL] [Abstract][Full Text] [Related]
9. Cell density-dependent regulation of hepatic development by a gp130-independent pathway.
Kojima N; Kinoshita T; Kamiya A; Nakamura K; Nakashima K; Taga T; Miyajima A
Biochem Biophys Res Commun; 2000 Oct; 277(1):152-8. PubMed ID: 11027656
[TBL] [Abstract][Full Text] [Related]
10. Signal transducer and activator of transcription STAT3 plays a major role in gp130-mediated acute phase protein gene activation.
May P; Schniertshauer U; Gerhartz C; Horn F; Heinrich PC
Acta Biochim Pol; 2003; 50(3):595-601. PubMed ID: 14515142
[TBL] [Abstract][Full Text] [Related]
11. STAT3 is dispensable for maintenance of self-renewal in nonhuman primate embryonic stem cells.
Sumi T; Fujimoto Y; Nakatsuji N; Suemori H
Stem Cells; 2004; 22(5):861-72. PubMed ID: 15342949
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy.
Selander KS; Li L; Watson L; Merrell M; Dahmen H; Heinrich PC; Müller-Newen G; Harris KW
Cancer Res; 2004 Oct; 64(19):6924-33. PubMed ID: 15466183
[TBL] [Abstract][Full Text] [Related]
13. IL-6 signal transduction and its physiological roles: the signal orchestration model.
Kamimura D; Ishihara K; Hirano T
Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
[TBL] [Abstract][Full Text] [Related]
14. Lack of gp130 expression in hepatocytes promotes liver injury.
Streetz KL; Wüstefeld T; Klein C; Kallen KJ; Tronche F; Betz UA; Schütz G; Manns MP; Müller W; Trautwein C
Gastroenterology; 2003 Aug; 125(2):532-43. PubMed ID: 12891556
[TBL] [Abstract][Full Text] [Related]
15. Roles of STAT3 defined by tissue-specific gene targeting.
Akira S
Oncogene; 2000 May; 19(21):2607-11. PubMed ID: 10851059
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells.
Sawa S; Kamimura D; Jin GH; Morikawa H; Kamon H; Nishihara M; Ishihara K; Murakami M; Hirano T
J Exp Med; 2006 Jun; 203(6):1459-70. PubMed ID: 16717113
[TBL] [Abstract][Full Text] [Related]
17. Conditional gene ablation of Stat3 reveals differential signaling requirements for survival of motoneurons during development and after nerve injury in the adult.
Schweizer U; Gunnersen J; Karch C; Wiese S; Holtmann B; Takeda K; Akira S; Sendtner M
J Cell Biol; 2002 Jan; 156(2):287-97. PubMed ID: 11807093
[TBL] [Abstract][Full Text] [Related]
18. Involvement of STAT3-regulated hepatic soluble factors in attenuation of stellate cell activity and liver fibrogenesis in mice.
Shigekawa M; Takehara T; Kodama T; Hikita H; Shimizu S; Li W; Miyagi T; Hosui A; Tatsumi T; Ishida H; Kanto T; Hiramatsu N; Hayashi N
Biochem Biophys Res Commun; 2011 Mar; 406(4):614-20. PubMed ID: 21356197
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma.
Moran DM; Mayes N; Koniaris LG; Cahill PA; McKillop IH
Liver Int; 2005 Apr; 25(2):445-57. PubMed ID: 15780071
[TBL] [Abstract][Full Text] [Related]
20. Bile acids inhibit interleukin-6 signaling via gp130 receptor-dependent and -independent pathways in rat liver.
Graf D; Kohlmann C; Haselow K; Gehrmann T; Bode JG; Häussinger D
Hepatology; 2006 Nov; 44(5):1206-17. PubMed ID: 17058237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
